Pharmacoresistant epilepsy was associated with a genotype leading to increased expression of P-glycoprotein [15], and increased P-glycoprotein expression has been observed in hippocampal tissue of refractory epilepsy patients and in rat epilepsy models [16, 17]. The gene discussed is ABCB1; the disease is epilepsy.